In a new web video, Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott discusses the critical role and value of pharmacy benefit companies, the root cause of high prescription drug prices, and how solutions to boost competition, especially
Thanks to PBMs’ efforts to give patients an incentive to use them and pharmacies an incentive to purchase them at the lowest prices, generics are widely available and affordable for hundreds of millions of Americans.
JC Scott, president and CEO of the PBMs’ national trade group, the Pharmaceutical Care Management Association, said in a statement: “We are currently reviewing the proposed rule. However, previous point-of-sale proposals in Medicare have not advanced because they would significantly increase Medicare spending.”
Over the last several years, it has become increasingly apparent that there is a growing data discrepancy between reports that rely on data from the independent pharmacy advocate and the lobbyist organization – National Community Pharmacists Association (NCPA) and the
The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken
A recent article (“The Corporate Scam that Even Trump Opposes: PBMs”) attacks the one industry that is both reducing prescription drug costs and improving quality: pharmacy benefit managers (PBMs). The White House fiscal year 2019 budget included many cost-saving items PBMs have
Over the last five years, the marketplace for independent pharmacies has experienced small fluctuations from year-to-year sometimes gaining stores, sometimes losing stores. These recent fluctuations in the overall number of stores have not dramatically shifted the independent pharmacy market.
Kristen Pumphrey is Senior Director of Conferences for PCMA. As the Association’s conference planner, she manages all aspects of site selection and coordination, vendor management, speaker recruitment, registration and onsite management. Previously, as Meetings Coordinator with the American Academy of
The independent pharmacy lobby is urging state legislatures to enact new legislation targeting pharmacy benefit managers (PBMs) that would increase fees and/or add surcharges to transactions with pharmacies. This is based upon two arguments: 1) that independent pharmacies are becoming
©2024 PCMA. All Rights Reserved.
